Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2009
11/11/2009CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558698C Calcium receptor-active compounds
11/11/2009CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009CN100558407C Preparation of aqueous clear solution dosage forms with bile acids
11/11/2009CN100558355C Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
11/11/2009CN100558345C Method for preparing vitamin A and vitamin E nano-sphere/microsphere double-embedding system
11/11/2009CN100558255C Method for preparing ageratum and purple common perilla fish-jam
11/11/2009CN100558254C Method for preparing ageratum and elsholtzia type roasting jam
11/11/2009CN100558243C A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
11/10/2009US7615679 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
11/10/2009US7615575 Compounds for the treatment of metabolic disorders
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615207 Methods for treating irritable bowel syndrome
11/10/2009US7614135 Method for making reservoir-based sensor device
11/10/2009CA2513064C Nanoparticulate topiramate formulations
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/10/2009CA2454500C Crystalline forms vi and vii of atorvastatin calcium
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2280612C Amino acid-sugar composition
11/05/2009WO2009134147A1 Lipid compositions containing derivatives of epa and dha an their use thereof
11/05/2009WO2009133970A1 Crystalline compound
11/05/2009WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase
11/05/2009WO2009133694A1 Bone strengthening food supplement
11/05/2009WO2009133692A1 Quinoline compound
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133647A1 Polymerized cyclic nitroxide radical compound, and use thereof
11/05/2009WO2009133458A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
11/05/2009WO2009133452A1 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1
11/05/2009WO2009133136A1 Compounds
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009132593A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof
11/05/2009WO2009132478A1 Synthesis of timosaponin bii
11/05/2009WO2009132463A1 New deodorization method and organoleptic improvement of marine oil extracts
11/05/2009WO2009109643A3 Use of interleukin-1 conjugates in the treatment of diabetes
11/05/2009WO2009102460A3 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009085226A3 Inhibitors of cdc2-like kinases (clks) and methods of use thereof
11/05/2009WO2009046879A3 Use of the combination of npy and nociceptin as a therapeutic agent
11/05/2009WO2009043526A3 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent
11/05/2009WO2009040051A9 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent
11/05/2009WO2009040005A9 Use of the peptide rfmwmr as a therapeutic agent
11/05/2009WO2009033819A3 Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids
11/05/2009WO2009033797A3 Use of apelin-17 and peptide yy as therapeutic agents, eg for treating hbv infection
11/05/2009WO2009033785A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hiv infection
11/05/2009WO2009033784A3 Use of apelin-13 (qrprlshkgpmpf) and optionally aplha-casein (90-96) as a therapeutic agents in eg the treatment of hiv infection
11/05/2009WO2009033738A3 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
11/05/2009WO2009033712A3 Use of melanotan ii as a therapeutic agent
11/05/2009US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
11/05/2009US20090275618 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as cb1 receptor modulators
11/05/2009US20090275613 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009US20090275590 (1-azinone)-substituted pyridoindoles
11/05/2009US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275563 Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
11/05/2009US20090275530 Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety
11/05/2009US20090275511 Analogs of ghrelin substituted at the n-terminal
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009US20090274784 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/05/2009US20090274782 Anti-obesity agent
11/05/2009US20090274778 Compositions Exhibiting Inhibition Of Cyclooxygenase-2
11/05/2009US20090274777 Dietetic composition
11/05/2009US20090274768 Fraktionen aus molkepermeat und deren verwendung zur pravention und therapie des typ-2 diabetes und des metabolischen syndroms
11/05/2009US20090274758 Solid Composition for Intra-Oral Delivery of Insulin
11/05/2009US20090274732 Type-2 Diabetes Combination Wafer
11/05/2009US20090274702 Method of treatment and Agents useful for same
11/05/2009US20090274680 Human Phospholipases
11/05/2009US20090274674 Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
11/05/2009CA2723132A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
11/05/2009CA2723118A1 Polymerized cyclic nitroxide radical compound and use thereof
11/05/2009CA2722798A1 Synthesis of timosaponin bii
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722628A1 Super fast-acting insulin compositions
11/05/2009CA2722487A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/05/2009CA2713379A1 Optimized methods for delivery of dsrna targeting the pcsk9 gene
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP1624874B1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1272049B1 Method for the fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation
11/04/2009CN101573357A 吲哚化合物 Indole compound
11/04/2009CN101573354A Substituted isoquinolines and their use as Rho-kinase inhibitors
11/04/2009CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009CN101573133A PEGylated, extended insulins
11/04/2009CN101570510A Quinoline compound, pharmaceutical composition, preparation method and application thereof
11/04/2009CN101569687A Herbal medicine for osteoporosis and related conditions
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612198 Low reducing sugar content, high level of alpha glucoside bonds, narrow range of high molecular weights, specific branched chain length distribution profile; low intrinsic viscosity; food, and medical applications
11/03/2009US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009US7612174 Scavenger receptor
11/03/2009US7612114 Selective estrogen receptor modulator
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 1298